Nantahala Capital Management, LLC 13D/13G Filings for Merrimack Pharmaceuticals, Inc. (MACK)

Nantahala Capital Management, LLC 13D and 13G filings for Merrimack Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
08:19 am
Sale
2021-12-3113GMERRIMACK PHARMACEUTICALS INC
MACK
Nantahala Capital Management, LLC569,971
4.300%
-181,872decrease
(-24.19%)
Filing